ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/28 | 1,607 | 1,626 | 1,593 | 1,601 | -26 | -1.6% | 350,300 |
2021/10/27 | 1,641 | 1,651 | 1,623 | 1,627 | -10 | -0.6% | 344,000 |
2021/10/26 | 1,612 | 1,640 | 1,595 | 1,637 | +47 | +3% | 338,500 |
2021/10/25 | 1,601 | 1,619 | 1,570 | 1,590 | -35 | -2.2% | 512,400 |
2021/10/22 | 1,617 | 1,660 | 1,602 | 1,625 | +8 | +0.5% | 425,100 |
2021/10/21 | 1,682 | 1,689 | 1,617 | 1,617 | -97 | -5.7% | 617,200 |
2021/10/20 | 1,682 | 1,759 | 1,652 | 1,714 | +24 | +1.4% | 806,300 |
2021/10/19 | 1,715 | 1,738 | 1,674 | 1,690 | -30 | -1.7% | 504,500 |
2021/10/18 | 1,753 | 1,753 | 1,709 | 1,720 | -44 | -2.5% | 438,700 |
2021/10/15 | 1,718 | 1,764 | 1,700 | 1,764 | +66 | +3.9% | 673,000 |
2021/10/14 | 1,669 | 1,710 | 1,660 | 1,698 | +48 | +2.9% | 381,300 |
2021/10/13 | 1,695 | 1,702 | 1,640 | 1,650 | -49 | -2.9% | 451,400 |
2021/10/12 | 1,664 | 1,714 | 1,645 | 1,699 | +31 | +1.9% | 527,700 |
2021/10/11 | 1,627 | 1,668 | 1,606 | 1,668 | +55 | +3.4% | 399,900 |
2021/10/08 | 1,580 | 1,616 | 1,572 | 1,613 | +54 | +3.5% | 454,400 |
2021/10/07 | 1,556 | 1,588 | 1,546 | 1,559 | +6 | +0.4% | 503,300 |
2021/10/06 | 1,596 | 1,617 | 1,527 | 1,553 | -43 | -2.7% | 891,600 |
2021/10/05 | 1,601 | 1,639 | 1,579 | 1,596 | -45 | -2.7% | 808,500 |
2021/10/04 | 1,751 | 1,763 | 1,607 | 1,641 | -109 | -6.2% | 1,317,500 |
2021/10/01 | 1,636 | 1,798 | 1,628 | 1,750 | +106 | +6.4% | 1,682,100 |
2021/09/30 | 1,678 | 1,705 | 1,615 | 1,644 | +86 | +5.5% | 1,371,100 |
2021/09/29 | 1,521 | 1,562 | 1,514 | 1,558 | +5 | +0.3% | 376,100 |
2021/09/28 | 1,540 | 1,554 | 1,518 | 1,553 | +8 | +0.5% | 366,400 |
2021/09/27 | 1,555 | 1,560 | 1,527 | 1,545 | -7 | -0.5% | 307,400 |
2021/09/24 | 1,515 | 1,556 | 1,511 | 1,552 | +67 | +4.5% | 526,300 |
2021/09/22 | 1,499 | 1,522 | 1,483 | 1,485 | -15 | -1% | 610,100 |
2021/09/21 | 1,483 | 1,518 | 1,480 | 1,500 | -63 | -4% | 721,400 |
2021/09/17 | 1,536 | 1,563 | 1,507 | 1,563 | +24 | +1.6% | 617,000 |
2021/09/16 | 1,618 | 1,627 | 1,533 | 1,539 | -97 | -5.9% | 984,800 |
2021/09/15 | 1,670 | 1,679 | 1,620 | 1,636 | -44 | -2.6% | 449,200 |
2021/09/14 | 1,656 | 1,686 | 1,648 | 1,680 | +22 | +1.3% | 426,600 |
2021/09/13 | 1,663 | 1,670 | 1,635 | 1,658 | -11 | -0.7% | 320,000 |
2021/09/10 | 1,663 | 1,671 | 1,632 | 1,669 | +34 | +2.1% | 539,700 |
2021/09/09 | 1,602 | 1,696 | 1,599 | 1,635 | +24 | +1.5% | 892,100 |
2021/09/08 | 1,593 | 1,620 | 1,583 | 1,611 | +17 | +1.1% | 375,400 |
2021/09/07 | 1,581 | 1,603 | 1,574 | 1,594 | +17 | +1.1% | 449,500 |
2021/09/06 | 1,580 | 1,589 | 1,563 | 1,577 | -3 | -0.2% | 481,300 |
2021/09/03 | 1,575 | 1,604 | 1,562 | 1,580 | +8 | +0.5% | 433,000 |
2021/09/02 | 1,616 | 1,619 | 1,566 | 1,572 | -33 | -2.1% | 407,400 |
2021/09/01 | 1,564 | 1,606 | 1,517 | 1,605 | +51 | +3.3% | 876,500 |
2021/08/31 | 1,595 | 1,604 | 1,543 | 1,554 | -43 | -2.7% | 839,900 |
2021/08/30 | 1,623 | 1,635 | 1,595 | 1,597 | -26 | -1.6% | 481,300 |
2021/08/27 | 1,596 | 1,627 | 1,573 | 1,623 | +29 | +1.8% | 496,400 |
2021/08/26 | 1,608 | 1,610 | 1,570 | 1,594 | +9 | +0.6% | 381,500 |
2021/08/25 | 1,605 | 1,610 | 1,556 | 1,585 | -12 | -0.8% | 615,900 |
2021/08/24 | 1,637 | 1,646 | 1,596 | 1,597 | -21 | -1.3% | 447,600 |
2021/08/23 | 1,617 | 1,642 | 1,602 | 1,618 | +6 | +0.4% | 447,400 |
2021/08/20 | 1,596 | 1,642 | 1,596 | 1,612 | +11 | +0.7% | 502,900 |
2021/08/19 | 1,621 | 1,643 | 1,586 | 1,601 | -33 | -2% | 616,100 |
2021/08/18 | 1,626 | 1,643 | 1,590 | 1,634 | -2 | -0.1% | 628,800 |
851~
900
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 218,100円 | +21.7% | +999.9% | 0.00% | 9.08倍 | 3.00倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 231,200円 | +14.2% | +41.0% | 1.99% | 11.32倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 304,500円 | +3.0% | +27.5% | 2.63% | 19.28倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 222,000円 | +0.4% | -8.4% | 2.39% | 28.50倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム